Skip to main content
. 2016 May 2;11(5):e0152306. doi: 10.1371/journal.pone.0152306

Table 2. Baseline characteristics categorized by 24h potassium excretion.

24h urinary potassium excretion
Variable Overall <1.5 g/day 1.5–2.0 g/day 2.0–2.5 g/day 2.5–3.0 g/day >3.0 g/day P-value
Number of patients 1230 242 349 301 194 144
24h urinary potassium excretion, g/day 2.14 (0.77) 1.23 (0.21) 1.75 (0.14) 2.24 (0.14) 2.72 (0.15) 3.64 (0.62) <0.001
Age, years 62.2 (10.9) 63.4 (11.6) 61.3 (11.3) 62.6 (9.3) 61.1 (12.0) 62.7 (9.7) 0.100
Male, n (%) 651 (52.9) 109 (45.0) 164 (47.0) 181 (60.1) 111 (57.2) 86 (59.7) <0.001
Height, cm 159.0 (9.1) 156.5 (9.5) 158.1 (8.9) 159.8 (8.8) 160.7 (8.7) 161.3 (9.4) <0.001
Weight, kg 61.5 (11.6) 57.4 (9.4) 61.2 (11.9) 62.5 (10.7) 63.1 (12.0) 65.1 (14.1) <0.001
BMI, kg/m2 24.2 (3.6) 23.4 (3.4) 24.4 (3.8) 24.4 (3.4) 24.3 (3.4) 24.7 (3.6) 0.003
Systolic BP, mmHg 131.7 (17.5) 131.6 (18.5) 133.2 (18.7) 129.9 (16.6) 131.3 (16.2) 133.0 (16.3) 0.156
Diastolic BP, mmHg 72.6 (12.2) 71.7 (12.9) 72.7 (12.7) 72.4 (11.7) 72.9 (10.7) 73.9 (12.6) 0.541
Type 2 diabetes, n (%) 1112 (90.4) 211 (87.2) 321 (92.0) 278 (92.4) 173 (89.2) 129 (89.6) 0.227
Diabetes duration, years 12.0 (8.0) 12.4 (8.6) 12.4 (8.2) 11.9 (7.8) 11.7 (7.5) 11.2 (7.7) 0.558
Diabetic retinopathy, n (%) 479 (38.9) 93 (38.4) 147 (42.1) 116 (38.5) 70 (36.1) 53 (36.8) 0.649
History of CVD, n (%) 250 (20.3) 50 (20.7) 81 (23.2) 69 (22.9) 34 (17.5) 16 (11.1) 0.021
Oral hypoglycemic agent, n (%) 818 (66.5) 154 (63.6) 242 (69.3) 201 (66.8) 130 (67.0) 91 (63.2) 0.576
Insulin, n (%) 408 (33.2) 89 (36.8) 118 (33.8) 92 (30.6) 59 (30.4) 50 (34.7) 0.520
RAAS blockade, n (%) 611 (49.7) 124 (51.2) 191 (54.7) 144 (47.8) 87 (44.8) 65 (45.1) 0.126
Calcium channel blocker, n (%) 456 (37.1) 99 (40.9) 135 (38.7) 109 (36.2) 67 (34.5) 46 (31.9) 0.384
Diuretics, n (%) 137 (11.1) 38 (15.7) 45 (12.9) 25 (8.3) 17 (8.8) 12 (8.3) 0.028
Statin, n (%) 440 (35.8) 88 (36.4) 136 (39.0) 96 (31.9) 79 (40.7) 41 (28.5) 0.062
Total protein, g/dl 7.48 (0.45) 7.47 (0.46) 7.44 (0.46) 7.50 (0.44) 7.48 (0.41) 7.54 (0.45) 0.254
Serum albumin, g/dl 4.39 (0.26) 4.35 (0.29) 4.37 (0.26) 4.41 (0.26) 4.44 (0.24) 4.43 (0.23) <0.001
Serum uric acid, mg/dl 5.07 (1.37) 4.91 (1.39) 5.11 (1.35) 5.11 (1.36) 5.10 (1.39) 5.13 (1.40) 0.394
Serum creatinine, mg/dl 0.72 (0.19) 0.72 (0.20) 0.73 (0.19) 0.73 (0.18) 0.73 (0.19) 0.70 (0.16) 0.441
eGFR, ml/min/1.73m2 78.6 (19.5) 78.2 (21.4) 77.2 (19.7) 78.6 (18.1) 79.5 (20.4) 81.5 (16.8) 0.236
HbA1c, % 7.26 (0.95) 7.22 (0.88) 7.26 (0.88) 7.27 (1.03) 7.34 (1.09) 7.15 (0.87) 0.413
Serum sodium, mEq/l 139.6 (1.8) 139.9 (1.9) 139.7 (1.9) 139.5 (1.8) 139.2 (1.9) 139.5 (1.6) 0.003
Serum potassium, mEq/l 4.44 (0.37) 4.31 (0.39) 4.42 (0.36) 4.48 (0.39) 4.50 (0.37) 4.51 (0.31) <0.001
Serum chloride, mEq/l 104.3 (2.4) 104.4 (2.7) 104.6 (2.3) 104.2 (2.3) 104.0 (2.2) 104.1 (2.2) 0.03
Total cholesterol, mg/dl 198.8 (34.7) 197.1 (35.1) 201.8 (34.8) 198.3 (34.3) 198.2 (35.6) 196.6 (33.6) 0.425
HDL cholesterol, mg/dl 53.3 (14.0) 54.1 (14.5) 52.9 (13.6) 52.4 (13.4) 53.3 (13.1) 55.2 (15.9) 0.309
24h urinary albumin excretion, mg/day 44.4 (117.9) 41.5 (101.3) 57.7 (163.3) 34.7 (81.7) 34.7 (104.8) 50.6 (87.6) 0.080
24h urinary sodium excretion, g/day 4.50 (1.64) 3.51 (1.24) 4.23 (1.36) 4.63 (1.40) 4.99 (1.61) 5.87 (2.10) <0.001

Categorical variables are expressed as the number (%) and continuous variables are expressed as the mean (SD).

BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; RAAS, renin-angiotensin-aldosterone system; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein